Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of RxSight Inc (NASDAQ: RXST) was $26.12 for the day, up 3.57% from the previous closing price of $25.22. In other words, the price has increased by $3.57 from its previous closing price. On the day, 0.74 million shares were traded. RXST stock price reached its highest trading level at $26.38 during the session, while it also had its lowest trading level at $24.81.
Ratios:
Our analysis of RXST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.50 and its Current Ratio is at 11.36. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on December 20, 2024, Downgraded its rating to Hold and sets its target price to $40 from $65 previously.
On December 11, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $56 to $42.
On December 06, 2024, UBS started tracking the stock assigning a Buy rating and target price of $52.UBS initiated its Buy rating on December 06, 2024, with a $52 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 12 ’25 when Fountain Tamara sold 7,000 shares for $25.71 per share. The transaction valued at 180,002 led to the insider holds 24,793 shares of the business.
TAMARA R FOUNTAIN bought 7,000 shares of RXST for $180,002 on Mar 12 ’25. On Jan 22 ’25, another insider, Maniar Shweta, who serves as the Director of the company, sold 3,519 shares for $30.87 each. As a result, the insider received 108,618 and left with 7,383 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXST now has a Market Capitalization of 1057611904 and an Enterprise Value of 796244480. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.56 while its Price-to-Book (P/B) ratio in mrq is 3.75. Its current Enterprise Value per Revenue stands at 5.69 whereas that against EBITDA is -23.923.
Stock Price History:
The Beta on a monthly basis for RXST is 1.25, which has changed by -0.4976923 over the last 52 weeks, in comparison to a change of 0.101756096 over the same period for the S&P500. Over the past 52 weeks, RXST has reached a high of $66.54, while it has fallen to a 52-week low of $24.09. The 50-Day Moving Average of the stock is -9.33%, while the 200-Day Moving Average is calculated to be -39.05%.
Shares Statistics:
RXST traded an average of 606.40K shares per day over the past three months and 567000 shares per day over the past ten days. A total of 40.43M shares are outstanding, with a floating share count of 38.38M. Insiders hold about 5.20% of the company’s shares, while institutions hold 87.20% stake in the company. Shares short for RXST as of 1741910400 were 2837244 with a Short Ratio of 4.68, compared to 1739491200 on 2407404. Therefore, it implies a Short% of Shares Outstanding of 2837244 and a Short% of Float of 7.35.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
